Real-time disaster intelligence, alerts, and response tools.
Friday, March 20, 2026
[ad_1] ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced […]
[ad_1] ROCKVILLE, Md. and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced […]
[ad_1] ROCKVILLE, Md. and SUZHOU, China, Nov. 24, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced […]
[ad_1] ROCKVILLE, Md. and SUZHOU, China, Nov. 21, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, announced […]
[ad_1] ROCKVILLE, Md. and SUZHOU, China, Nov. 17, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today […]
